326 related articles for article (PubMed ID: 15001459)
1. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
Schmitt M; Gunaruwan P; Payne N; Taylor J; Lee L; Broadley AJ; Nightingale AK; Cockcroft JR; Struthers AD; Tyberg JV; Frenneaux MP
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):911-7. PubMed ID: 15001459
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans.
Schmitt M; Broadley AJ; Nightingale AK; Payne N; Gunaruwan P; Taylor J; Lee L; Cockcroft J; Struthers AD; Frenneaux MP
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1833-8. PubMed ID: 12842844
[TBL] [Abstract][Full Text] [Related]
3. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
[TBL] [Abstract][Full Text] [Related]
4. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.
Nakamura M; Arakawa N; Yoshida H; Makita S; Hiramori K
Circulation; 1994 Sep; 90(3):1210-4. PubMed ID: 8087930
[TBL] [Abstract][Full Text] [Related]
5. Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation.
Brunner F; Wölkart G
Microvasc Res; 2001 Jan; 61(1):102-10. PubMed ID: 11162200
[TBL] [Abstract][Full Text] [Related]
6. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.
Nakamura M; Arakawa N; Yoshida H; Makita S; Niinuma H; Hiramori K
Am Heart J; 1998 Mar; 135(3):414-20. PubMed ID: 9506326
[TBL] [Abstract][Full Text] [Related]
7. Vascular effects of natriuretic peptides in healthy men.
Komarek M; Bernheim A; Schindler R; Steden R; Kiowski W; Brunner-La Rocca HP
J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):263-70. PubMed ID: 15678245
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison of relaxation and cGMP production in human coronary by-pass grafts in response to stimulation with natriuretic peptides and a nitric oxide donor.
Hammerer-Lercher A; Fersterer J; Holzmann S; Bonatti J; Ruttmann E; Hoefer D; Mair J; Puschendorf B
Clin Sci (Lond); 2006 Sep; 111(3):225-31. PubMed ID: 16709152
[TBL] [Abstract][Full Text] [Related]
9. An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure.
Ishibashi Y; Shimada T; Murakami Y; Takahashi N; Sakane T; Sugamori T; Ohata S; Inoue S; Ohta Y; Nakamura K; Shimizu H; Katoh H; Hashimoto M
J Am Coll Cardiol; 2001 Nov; 38(5):1470-6. PubMed ID: 11691525
[TBL] [Abstract][Full Text] [Related]
10. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
Yamamoto K; Ikeda U; Shimada K
J Mol Cell Cardiol; 1997 Sep; 29(9):2375-82. PubMed ID: 9299361
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide preserves endothelial function during intimal hyperplasia.
Barber MN; Gaspari TA; Kairuz EM; Dusting GJ; Woods RL
J Vasc Res; 2005; 42(2):101-10. PubMed ID: 15665545
[TBL] [Abstract][Full Text] [Related]
13. Role of natriuretic peptides in regulation of conduit artery distensibility.
Schmitt M; Qasem A; McEniery C; Wilkinson IB; Tatarinoff V; Noble K; Klemes J; Payne N; Frenneaux MP; Cockcroft J; Avolio A
Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1167-71. PubMed ID: 15317675
[TBL] [Abstract][Full Text] [Related]
14. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
[TBL] [Abstract][Full Text] [Related]
15. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptides and their therapeutic potential.
Cho Y; Somer BG; Amatya A
Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
[TBL] [Abstract][Full Text] [Related]
17. Slower onset of vasodilating action of brain natriuretic peptide (BNP) compared to atrial natriuretic peptide (ANP) in human forearm resistant vessels.
Minami H; Yasu T; Tagawa T; Yamakawa K; Ueda S
Eur J Clin Pharmacol; 2008 Sep; 64(9):859-62. PubMed ID: 18622600
[TBL] [Abstract][Full Text] [Related]
18. Effects of nitric oxide inhibition on basal forearm blood flow in patients with nonischemic chronic heart failure.
Yoshida H; Nakamura M; Akatsu T; Arakawa N; Hiramori K
Heart Vessels; 1998; 13(3):142-6. PubMed ID: 10328184
[TBL] [Abstract][Full Text] [Related]
19. Abnormal desmopressin-induced forearm vasodilatation in patients with heart failure: dependence on nitric oxide synthase activity.
Rector TS; Bank AJ; Tschumperlin LK; Mullen KA; Lin KA; Kubo SH
Clin Pharmacol Ther; 1996 Dec; 60(6):667-74. PubMed ID: 8988069
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.
Hobbs A; Foster P; Prescott C; Scotland R; Ahluwalia A
Circulation; 2004 Sep; 110(10):1231-5. PubMed ID: 15337698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
